0000950123-11-102356.txt : 20111207 0000950123-11-102356.hdr.sgml : 20111207 20111207171918 ACCESSION NUMBER: 0000950123-11-102356 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20111207 DATE AS OF CHANGE: 20111207 GROUP MEMBERS: DR. ALASTAIR J.J. WOOD GROUP MEMBERS: HARRI V. TARANTO GROUP MEMBERS: MARK KESSEL GROUP MEMBERS: SYMPHONY CAPITAL GP, L.P. GROUP MEMBERS: SYMPHONY CAPITAL PARTNERS, L.P. GROUP MEMBERS: SYMPHONY GP, LLC GROUP MEMBERS: SYMPHONY VIDA HOLDINGS LLC FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KESSEL MARK CENTRAL INDEX KEY: 0001222013 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 950 PARK AVE APT. 11A CITY: NEW YORK STATE: NY ZIP: 10028 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-45691 FILM NUMBER: 111249316 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 SC 13D/A 1 b89462sc13dza.htm SC 13D/A sc13dza
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934
(Amendment No. 5)

OXIGENE, INC.
(Name of Issuer)
Common Stock, Par Value $0.01 Per Share
(Title of Class of Securities)
691828107
(CUSIP Number)
Mark Kessel
Symphony Capital Partners, L.P.
875 Third Avenue
3rd Floor
New York, NY 10022
(212) 632-5400
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
October 31, 2011
(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 

TABLE OF CONTENTS

ITEM 1. SECURITY AND ISSUER
ITEM 2.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
ITEM 4. PURPOSE OF TRANSACTION
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH            RESPECT TO SECURITIES OF THE ISSUER
SIGNATURE

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
2 
   of   
17 Pages 
SCHEDULE 13D/A

 

           
1   NAME OF REPORTING PERSON

Symphony Capital Partners, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
  (a)   o 
  (b)   þ 
     
3   SEC USE ONLY
   
   
     
4   SOURCE OF FUNDS
   
  OO
     
5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  7   SOLE VOTING POWER
     
NUMBER OF   -0-
       
SHARES 8   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,355,855
       
EACH 9   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   -0-
       
WITH 10   SHARED DISPOSITIVE POWER
     
    1,355,855
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,355,855
     
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
   
  9.11%
     
14   TYPE OF REPORTING PERSON
   
  PN

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
3 
   of   
17 Pages 
SCHEDULE 13D/A

 

           
1   NAME OF REPORTING PERSON

Symphony Capital GP, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
  (a)   o 
  (b)   þ 
     
3   SEC USE ONLY
   
   
     
4   SOURCE OF FUNDS
   
  OO
     
5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  7   SOLE VOTING POWER
     
NUMBER OF   -0-
       
SHARES 8   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,355,855
       
EACH 9   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   -0-
       
WITH 10   SHARED DISPOSITIVE POWER
     
    1,355,855
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,355,855
     
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
   
  9.11%
     
14   TYPE OF REPORTING PERSON
   
  PN

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
4 
   of   
17 Pages 
SCHEDULE 13D/A

 

           
1   NAME OF REPORTING PERSON

Symphony GP, LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
  (a)   o 
  (b)   þ 
     
3   SEC USE ONLY
   
   
     
4   SOURCE OF FUNDS
   
  OO
     
5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  7   SOLE VOTING POWER
     
NUMBER OF   -0-
       
SHARES 8   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,355,855
       
EACH 9   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   -0-
       
WITH 10   SHARED DISPOSITIVE POWER
     
    1,355,855
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,355,855
     
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
   
  9.11%
     
14   TYPE OF REPORTING PERSON
   
  OO

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
5 
   of   
17 Pages 
SCHEDULE 13D/A

 

           
1   NAME OF REPORTING PERSON

Mark Kessel
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
  (a)   o 
  (b)   þ 
     
3   SEC USE ONLY
   
   
     
4   SOURCE OF FUNDS
   
  OO
     
5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  7   SOLE VOTING POWER
     
NUMBER OF   5,750
       
SHARES 8   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,355,855
       
EACH 9   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   5,750
       
WITH 10   SHARED DISPOSITIVE POWER
     
    1,355,855
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,361,605
     
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
   
  9.15%
     
14   TYPE OF REPORTING PERSON
   
  IN

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
6 
   of   
17 Pages 
SCHEDULE 13D/A

 

           
1   NAME OF REPORTING PERSON

Harri V. Taranto
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
  (a)   o 
  (b)   þ 
     
3   SEC USE ONLY
   
   
     
4   SOURCE OF FUNDS
   
  OO
     
5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  7   SOLE VOTING POWER
     
NUMBER OF   -0-
       
SHARES 8   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,355,855
       
EACH 9   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   -0-
       
WITH 10   SHARED DISPOSITIVE POWER
     
    1,355,855
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,355,855
     
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
   
  9.11%
     
14   TYPE OF REPORTING PERSON
   
  IN

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
7 
   of   
17 Pages 
SCHEDULE 13D/A

 

           
1   NAME OF REPORTING PERSON

Dr. Alastair J.J. Wood
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
  (a)   o 
  (b)   þ 
     
3   SEC USE ONLY
   
   
     
4   SOURCE OF FUNDS
   
  OO
     
5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  7   SOLE VOTING POWER
     
NUMBER OF   17,871
       
SHARES 8   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   -0-
       
EACH 9   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   17,871
       
WITH 10   SHARED DISPOSITIVE POWER
     
    -0-
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  17,871
     
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
   
  0.04%
     
14   TYPE OF REPORTING PERSON
   
  IN

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
8 
   of   
17 Pages 
SCHEDULE 13D/A

 

           
1   NAME OF REPORTING PERSON

Symphony ViDA Holdings LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
  (a)   o 
  (b)   þ 
     
3   SEC USE ONLY
   
   
     
4   SOURCE OF FUNDS
   
  OO
     
5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  7   SOLE VOTING POWER
     
NUMBER OF   -0-
       
SHARES 8   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,355,855
       
EACH 9   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   -0-
       
WITH 10   SHARED DISPOSITIVE POWER
     
    1,355,855
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,355,855
     
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
   
  9.11%
     
14   TYPE OF REPORTING PERSON
   
  OO

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
9
   of   
17 Pages 
SCHEDULE 13D/A
ITEM 1. SECURITY AND ISSUER.
This Amendment No. 5 (this “Amendment No. 5”) amends the Initial Schedule 13D filed on October 1, 2008 (the “Initial 13D”), as amended by Amendment No. 1 filed on December 12, 2008, (“Amendment No. 1”), Amendment No. 2 filed on January 9, 2009 (“Amendment No. 2”), Amendment No. 3 filed on July 30, 2009 (“Amendment No. 3”) and Amendment No. 4 filed on December 18, 2009 (“Amendment No. 4” and together with Amendment No. 5, the Initial 13D, Amendment No. 1, Amendment No. 2 and Amendment No. 3, the “Schedule 13D”) which relates to the common stock, par value $0.01 per share (the “Common Stock”), of OXiGENE, Inc., a Delaware corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 701 Gateway Blvd., South San Francisco, CA 94080. This Amendment No. 5 is being filed to report a change to Items 2 (b) and 5 (a) — (c) of the Schedule 13D to reflect a change of address of each of the Reporting Persons and to update the number of shares of common stock held and applicable percentages resulting from the Issuer’s 1:20 reverse split, which became effective on February 22, 2011.
ITEM 2.
Item 2 of the Schedule 13D is hereby amended by the deletion of the text thereof in its entirety and its replacement with the following:
  (a)   The names of the persons filing under this Statement are Symphony Capital Partners, L.P. (“SCP”), Symphony Capital GP, L.P., Symphony GP, LLC, Mark Kessel, Harri V. Taranto, Dr. Alastair J.J. Wood and Symphony ViDA Holdings LLC (“Holdings” and collectively, the “Reporting Persons”). The attached Schedule A sets forth the controlling persons, the executive officers and the directors of SCP, Symphony Capital GP, L.P., Symphony GP, LLC and Holdings and contains the following information with respect to each such person: (i) name, (ii) citizenship and (iii) present principal occupation or employment and the name, principal business and address of any corporation or other organization in which such employment is conducted. Until October 31, 2011, when his term as a director expired at the Issuer’s 2011 annual meeting of stockholders, Mr. Kessel was a director of the Issuer. Dr. Wood remains as a director of the Issuer.
 
  (b)   The business address of each of the Reporting Persons is 875 Third Avenue, 3rd Floor, New York, NY 10022.
 
  (c)   Name of Reporting Person                                                            Principal Business/Occupation
     
Symphony Capital Partners, L.P.
  Manager of Symphony ViDA Holdings LLC and involved in purchasing, holding and selling securities and other investments.
 
    
Symphony Capital GP, L.P.
  General Partner of Symphony Capital Partners, L.P.
 
    
Symphony GP, LLC
  General Partner of Symphony Capital GP, L.P.
 
    
Mark Kessel
  Managing Member of Symphony GP, LLC
 
    

 

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
10 
   of   
17 Pages 
SCHEDULE 13D/A
     
Harri V. Taranto
  Managing Member of Symphony GP, LLC
 
    
Dr. Alastair J.J. Wood
  Limited partner in Symphony Capital GP, L.P.
 
    
Symphony ViDA Holdings LLC
  Involved in purchasing, holding and selling securities and other investments
 
    
  (d)   During the past five years, none of the persons referred to in paragraph (a) above has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
 
  (e)   During the past five years, none of the persons referred to in paragraph (a) above has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding, was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
 
  (f)   Name of Reporting Person                                                          Citizenship
     
Symphony Capital Partners, L.P.
  Delaware limited partnership.
 
    
Symphony Capital GP, L.P.
  Delaware limited partnership.
 
    
Symphony GP, LLC
  Delaware limited liability company
 
    
Mark Kessel
  United States Citizen
 
    
Harri V. Taranto
  United States Citizen
 
    
Dr. Alastair J.J. Wood
  United States Citizen
 
    
Symphony ViDA Holdings LLC
  Delaware limited liability company
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Not applicable.
ITEM 4. PURPOSE OF TRANSACTION.
No material change.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5(a) — (d) of the Schedule 13D is hereby amended by the deletion of the text thereof in its entirety and its replacement with the following:

 

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
11 
   of   
17 Pages 
SCHEDULE 13D/A
  (a)   Each of the Reporting Persons owns the following shares of Common Stock:
  (i)   Symphony Capital Partners, L.P.
Number of Shares of Common Stock: 1,355,855
Percentage Outstanding Common Stock: 9.11%
 
  (ii)   Symphony Capital GP, L.P.
Number of Shares of Common Stock: 1,355,855
Percentage Outstanding Common Stock: 9.11%
 
  (iii)   Symphony GP, LLC
Number of Shares of Common Stock: 1,355,855
Percentage Outstanding Common Stock: 9.11%
 
  (iv)   Mark Kessel
Number of Shares of Common Stock: 1,361,605
Percentage Outstanding Common Stock: 9.15%
 
  (v)   Harri V. Taranto
Number of Shares of Common Stock: 1,355,855
Percentage Outstanding Common Stock: 9.11%
 
  (vi)   Dr. Alastair J.J. Wood
Number of Shares of Common Stock: 17,871
Percentage Outstanding Common Stock: 0.04%
 
  (vii)   Symphony ViDA Holdings LLC
Number of Shares of Common Stock: 1,355,855
Percentage Outstanding Common Stock: 9.11%
The percentage of the Common Stock beneficially owned or deemed to be beneficially owned by each of the Reporting Persons as set forth above is based on 14,879,857 shares of Common Stock issued and outstanding as reported in the Issuer’s Form 10-Q filed on November 10, 2011.
  (b)   Each of the Reporting Persons holds the following voting and investment power:
  (i)   Symphony Capital Partners, L.P.
Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 1,355,855 shares
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or to direct the disposition: 1,355,855 shares
 
  (ii)   Symphony Capital GP, L.P.
Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 1,355,855 shares
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or to direct the disposition: 1,355,855 shares

 

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
12 
   of   
17 Pages 
SCHEDULE 13D/A
 
  (iii)   Symphony GP, LLC
Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 1,355,855 shares
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or to direct the disposition: 1,355,855 shares
 
  (iv)   Mark Kessel
Sole power to vote or direct the vote: 5,750 shares
Shared power to vote or direct the vote: 1,355,855 shares
Sole power to dispose or to direct the disposition: 5,750 shares
Shared power to dispose or to direct the disposition: 1,355,855 shares
 
  (v)   Harri V. Taranto
Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 1,355,855 shares
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or to direct the disposition: 1,355,855 shares
 
  (vi)   Dr. Alastair J.J. Wood
Sole power to vote or direct the vote: 17,871 shares
Shared power to vote or direct the vote: 0
Sole power to dispose or to direct the disposition: 17,871 shares
Shared power to dispose or to direct the disposition: 0
 
  (vii)   Symphony ViDA Holdings LLC
Sole power to vote or direct the vote: 0
Shared power to vote or direct the vote: 1,355,855 shares
Sole power to dispose or to direct the disposition: 0
Shared power to dispose or to direct the disposition: 1,355,855 shares
The voting and disposition power of the Common Stock beneficially owned or deemed to be beneficially owned by each of the Reporting Persons as set forth above is based on 14,879,857 shares of Common Stock issued and outstanding as reported in the Issuer’s Form 10-Q filed on November 10, 2011.
(c) Except for 12,121 shares of Common Stock granted to Dr. Alastair J.J. Wood on October 31, 2011 as compensation for service on the Board of Directors of the Issuer and included in the calculation of the Reporting Persons’ beneficial ownership of Common Stock reported herein, to the knowledge of the Reporting Persons with respect to the persons named in response to paragraph (a), none of the persons named in response to paragraph (a) has effected any transactions in shares of Common Stock during the past 60 days.

 

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
13 
   of   
17 Pages 
SCHEDULE 13D/A
(d) No person other than the persons listed is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any securities owned by any member of the group.
(e) Not applicable.
ITEM 6.   CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.
No material change.

 

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
14 
   of   
17 Pages 
SCHEDULE 13D/A
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated: December 7, 2011
         
  SYMPHONY CAPITAL PARTNERS, L.P.
 		  
  By:   Symphony Capital GP, L.P.    
    its general partner   
     
  By:   Symphony GP, LLC    
    its general partner   
     
  By:   /s/ Mark Kessel    
    Name:   Mark Kessel    
    Title:   Managing Member   
         
  SYMPHONY CAPITAL GP, L.P.
 		  
  By:   Symphony GP, LLC    
    its general partner   
     
  By:   /s/ Mark Kessel    
    Name:   Mark Kessel    
    Title:   Managing Member   
         
  SYMPHONY GP, LLC
 		  
  By:   /s/ Mark Kessel    
    Name:   Mark Kessel    
    Title:   Managing Member   

 

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
15 
   of   
17 Pages 
SCHEDULE 13D/A
         
  MARK KESSEL
 		  
       /s/ Mark Kessel    
    Name:   Mark Kessel    
    Title:   Managing Member   
         
  HARRI V. TARANTO
 		  
       /s/ Harri V. Taranto    
    Name:   Harri V. Taranto    
    Title:   Managing Member   
         
  DR. ALASTAIR J.J. WOOD
 		  
       /s/ Dr. Alastair J.J. Wood    
    Name:   Dr. Alastair J.J. Wood    
    Title:   Limited Partner   
         
  SYMPHONY ViDA HOLDINGS LLC
 		  
  By:   Symphony Capital Partners, L.P.    
    its Manager   
     
  By:   Symphony Capital GP, L.P.    
    its general partner   
     
  By:   Symphony GP, LLC    
    its general partner   
     
  By:   /s/ Mark Kessel    
    Name:   Mark Kessel    
    Title:   Managing Member   

 

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
16 
   of   
17 Pages 
SCHEDULE 13D/A
SCHEDULE A
SYMPHONY CAPITAL PARTNERS, L.P.
Mark Kessel
Managing Member
United States citizen
Symphony Capital Partners, L.P.
875 Third Avenue, 3rd Floor
New York, NY 10022
Harri V. Taranto
Managing Member
United States citizen
Symphony Capital Partners, L.P.
875 Third Avenue, 3rd Floor
New York, NY 10022
SYMPHONY CAPITAL GP, L.P.
Mark Kessel
Managing Member
United States citizen
Symphony Capital Partners, L.P.
875 Third Avenue, 3rd Floor
New York, NY 10022
Harri V. Taranto
Managing Member
United States citizen
Symphony Capital Partners, L.P.
875 Third Avenue, 3rd Floor
New York, NY 10022
SYMPHONY GP, LLC
Mark Kessel
Managing Member
United States citizen
Symphony Capital Partners, L.P.
875 Third Avenue, 3rd Floor
New York, NY 10022
Harri V. Taranto
Managing Member
United States citizen
Symphony Capital Partners, L.P.
875 Third Avenue, 3rd Floor
New York, NY 10022

 

Table of Contents

                     
CUSIP No.
  
691828107 
   Page  
17 
   of   
17 Pages 
SCHEDULE 13D/A
SYMPHONY ViDA HOLDINGS LLC
Mark Kessel
Managing Member
United States citizen
Symphony Capital Partners, L.P.
875 Third Avenue, 3rd Floor
New York, NY 10022
Harri V. Taranto
Managing Member
United States citizen
Symphony Capital Partners, L.P.
875 Third Avenue, 3rd Floor
New York, NY 10022